Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aplitude Medical Systems, Cardiofocus, Flatiron, Microbix Biosystems, Natera, Neuronetics, Owlet, Rhapsody, Sanara, Sekisui Diagnostics.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Augmedics, Hologic, Integra, Meduloc, Thermo Fisher Scientific, Welcony.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Tenpoint.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alebund, Carsgen, GC Biopharma, Hengrui, Hope Medicines, Takeda.

Biopharmas in Asia-Pacific raising money in public or private financings: Propanc.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Avenzo, Boehringer, City, Tenaya, UCB, Vera.

Biopharma happenings, including deals and partnerships, and other news in brief: AN2, Damora, Eli Lilly, Galecto, Genfit, GSK, Meiragtx, Teva, Transition, Voyager.

Clinical updates, including data readouts and publications: Adarx, Amgen, Anaptysbio, Apogee, Astrazeneca, Atai Beckley, Bioinvent, Bluejay, Camurus, Cogent, Inflarx, Ionis, Mannkind, Merck, Mineralys,  Neurogastrx, Novo Nordisk, Organon, Roche, Swedish Orphan Biovitrum, Vor.

Biopharmas raising money in public or private financings, including: Arch Biopartners, Evommune, Onchilles.

New hires and promotions in the biopharma industry, including: Acumen, Alpha-9, Celldex, Nurix, Onchilles, Quralis, Simris.